FDA Center for Drug Evaluation & Research Issues Warning Letter to SCA Pharmaceuticals
October 14, 2026
October 14, 2026
WASHINGTON, Oct. 14 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to SCA Pharmaceuticals, LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: Kenneth P. Bonnell, Chief Quality Officer, SCA Pharmaceuticals, LLC, 8821 Knoedl Court, Little Rock, AR 72205-4600, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING . . .
* * *
Recipient: Kenneth P. Bonnell, Chief Quality Officer, SCA Pharmaceuticals, LLC, 8821 Knoedl Court, Little Rock, AR 72205-4600, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING . . .